@TimLyonMD

Urologic Oncologist, Associate Professor of Urology, Mayo Clinic Florida @mayoclinic

 Jacksonville, FL
mayoclinic.org/biographies/lyon-timothy-d-m-d/bio-20466690
Joined June 2014
  • Tweets133
  • Following259
  • Followers458
18Media
Are toxicities & costs of ICIs + BCG worth the recurrence benefit in HR-NMIBC vs BCG alone? Calculator: geratcliff.shinyapps.io/blad… 💪 work led by @DDJoyce_BFA @SBoorjian 🙏 team:@DanBarocas @urogeek @UroCancerMD @VigneshPackiam @GSK_UofT @kevinwymer @BladderCancerUS @SUO_YUO
Journal of Urology
@JUrologyAug 28
Is Combo Therapy Worth It for Bladder Cancer? 🤔 A study examines combining ICIs with BCG for high-risk NMIBC treatment, revealing key insights on cost-effectiveness. 🩺 Slightly Effective - Only 0.12 extra QALYs with combo therapy 💰 Costly - 3x higher costs with combo: $222,770 vs. $67,630 ❌ Not Cost-Effective - ICER at $1,236,860/QALY 📉 Needs Price Cut - Sasanlimab price must drop by >87% to be viable tnyp.me/XM327HbV/x #BladderCancer #HealthcareCosts #CancerResearch
9
18
2,323
Dr. Amanda Black talks about her randomized clinical trial and how it shows that office-based laser photocoagulation is noninferior to TURBT at 12 months—offering a safe, efficient alternative that avoids general anesthesia and the OR for many patients 🔗bit.ly/4sryOud
1
8
1
19
3,195
#TrialsinProgress - In-home iNtraVesIcal ThErapy (INVITE) Study: A phase Ib/II, single-arm trial of delivering intravesical therapy for #BladderCancer in patients’ homes. Presentation by @TimLyonMD @MayoClinic. #SUO25 written coverage by @zklaassen_md @GACancerCenter > bit.ly/3YeDI0Q @UroOnc #SUO2025
7
18
1,146
Big congratulations to Chief resident, Dr. Ethan Wajswol for finishing in the top 5 at the Resident Bowl at the @SES_AUA meeting! He’s headed to Vegas to represent us at the AUA—well deserved! #AUA2025
2
1
18
1,164
Calling urology applicants for #Match2026! 📣 Join Mayo Clinic Florida @MayoUrology in Jacksonville for a 4-week Visiting Medical Student sub-internship. ⭐️ Apply through #VSLO ⭐️ Personal statement & CV required ⭐️ More info here: bit.ly/4h0L8Mk ⭐️ Stipend provided
9
1
21
3,816
Kidney cancer panel session at the Update in Urology Mayo Meeting. Dr Thiel is asking the tough questions but the panel is not fazed!
3
18
1,057
Tim Lyon retweeted
YUO
@SUO_YUO18 Jan 2025
🚨‼️@UroOnc fellows ‼️🚨 Are you interested in health policy? The SUO is sponsoring TWO fellows to attend the #AUASummit25 this March in DC! Learn about how advocacy efforts expand, strengthen and unify the voice of urology on policy matters impacting our field! Apply by Jan 31 ➡️ ellyr.r.sp1-brevo.net/mk/mr/… @UroOnc @WUO_SUO @AmerUrological
7
1
13
3,008
Update in Urology is headed to Puerto Rico in 2025! Join us in person or via livestream on February 26-March 1 for a comprehensive update on the field of clinical urology. mayocl.in/3Pw33Py @MayoUrology
6
2
15
3,831
Update in Urology is headed to Puerto Rico in 2025! Join us in person or via livestream on February 26-March 1 for a comprehensive update on the field of clinical urology. mayocl.in/48p5ZpU @MayoUrology
1
7
14
1,434
Very excited to share our work published in @UrologyPractice investigating Hospital-at-Home care for urologic inpatients. Check out our infographic below for key takeaways! Thank you to my mentor @TimLyonMD for his guidance and support! @MayoUrology auajournals.org/doi/full/10.…
3
6
2
27
4,174
Important findings in this paper - patients in MA plans often have limited access to specialists, even in high population/urban settings. A shame to see patients covered by Medicare again having access issues due to restrictive MA plans, especially for time sensitive conditions
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
1
2
11
3,300
The cell-based therapy TARA-002 demonstrated a favorable safety profile and preliminary anti-tumor activity in patients with high-risk NMIBC with carcinoma in situ, according to recent data. @TimLyonMD #blcsm #bladdercancer #urology Read more: urologytimes.com/view/cell-t…

Cell therapy TARA-002 shows initial promise in NMIBC | Urology Times

"This encouraging anti-tumor activity coupled with a favorable safety profile and mode of administration that is both convenient and familiar to urologists indicates that, if confirmed in future...

urologytimes.com
3
7
1,633
Excellent lecture from @TimLyonMD on in home therapy for bladder cancer patients - leading the INVITE trial looking at this further @urotoday #SESAUA
1
4
24
2,208
Replying to @TimLyonMD
@TimLyonMD discussing bladder cancer treatment at home. Wow! #SESAUA2024 – at Austin, TX
7
12
1,717
Are you a medical student interested in learning more about Urology at Mayo Clinic Florida? Apply for a summer clerkship using the link below: college.mayo.edu/academics/v… @TimLyonMD @ajzganjar @MayoUrology
6
10
2,407
Optimizing management of #NMIBC by @TimLyonMD at #mayourohawaii24 ✅ blue light is critical ✅ give intraves chemo post ✅ intermediate risk disease may benefit from further stratification for management (see image) ✅ cystectomy plays a role @MayoUrology
5
1
16
2,481
Congratulations @Ashley_Foret_, @ysaralee , and Benjamin Dalkin for matching into the Mayo Clinic Florida Urology residency! @MayoUrology
6
24
7
151
53,196
We examined the patient reported treatment burden of intravesical therapy and explored attitudes toward in-home therapy. Let’s discuss🧵@UrolOncol @BladderCancerUS Open access authors.elsevier.com/sd/arti… @TimLyonMD @benristau @MattMossanen @MarkTysonMD @bcan_chisolm @angiesmith_uro
2
14
37
7,758
Last week of residency complete ✅ Finished strong with 2 RALPs, 3 nephrectomies and an open revision. I am leaving with an immense amount of gratitude for my @MayoFL_UrolRes mentors @TimLyonMD @ajzganjar @RamPathakMD @rp982002
2
2
21
2,246
International Multi-institutional Characterization of the Perioperative Morbidity of Metastasectomy for Renal Cell Carcinoma buff.ly/3YnvIsI @TimLyonMD @Eduardrssl @vidit_sharma_ @pierocarames25 @SBoorjian @HThompsonMD @joniau @MaartenAlbersen @BradLeibovichMD
19
1
46
8,991
Load more